Publication | Closed Access

Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study

Translational MedicineFibrosisAntifibrotic TherapyOpen-label Extension StudyAdvanced Lung DiseaseIdiopathic Pulmonary FibrosisLong-term TreatmentPulmonary Alveolar ProteinosisPathologyPulmonary FibrosisPulmonary MedicineMedicinePulmonary Disease